1h Free Analyst Time
The publisher has been monitoring the renal biomarkers market and it is poised to grow by $507.23 mn during 2022-2026, decelerating at a CAGR of 7.40% during the forecast period. The report on the renal biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic kidney diseases and increase in incidence of acute kidney injury (AKI) and associated risk factors.
The renal biomarkers market analysis includes the end-user segment and geographic landscape.
The renal biomarkers market is segmented as below:
By End-user
- Hospitals
- Clinics and diagnostic laboratories
- Research laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the rapid increase in the aging population as one of the prime reasons driving the renal biomarkers market growth during the next few years.
The report on renal biomarkers market covers the following areas:
- Renal biomarkers market sizing
- Renal biomarkers market forecast
- Renal biomarkers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading renal biomarkers market vendors that include Abbott Laboratories, bioMerieux SA, BioPorto AS, F. Hoffmann-La Roche Ltd., IQVIA Holdings Inc., Randox Laboratories Ltd., RenalSense Ltd., Siemens AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc. Also, the renal biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals - Market size and forecast 2021-2026
- Clinics and diagnostic laboratories - Market size and forecast 2021-2026
- Research laboratories - Market size and forecast 2021-2026
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMerieux SA
- BioPorto AS
- F. Hoffmann-La Roche Ltd.
- IQVIA Holdings Inc.
- Randox Laboratories Ltd.
- RenalSense Ltd.
- Siemens AG
- SphingoTec GmbH
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- End-user - Market share 2021-2026 (%)
- Comparison by End-user
- Hospitals - Market size and forecast 2021-2026 ($ million)
- Hospitals - Year-over-year growth 2021-2026 (%)
- Clinics and diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
- Clinics and diagnostic laboratories - Year-over-year growth 2021-2026 (%)
- Research laboratories - Market size and forecast 2021-2026 ($ million)
- Research laboratories - Year-over-year growth 2021-2026 (%)
- Market opportunity by End-user
- Customer landscape
- Market share By Geographical Landscape 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Key customers
- Abbott Laboratories - Segment focus
- bioMerieux SA - Overview
- bioMerieux SA - Business segments
- bioMerieux SA - Key offerings
- bioMerieux SA - Key customers
- bioMerieux SA - Segment focus
- BioPorto AS - Overview
- BioPorto AS - Product and service
- BioPorto AS - Key offerings
- BioPorto AS - Key customers
- BioPorto AS - Segment focus
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Business segments
- F. Hoffmann-La Roche Ltd. - Key offerings
- F. Hoffmann-La Roche Ltd. - Key customers
- F. Hoffmann-La Roche Ltd. - Segment focus
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Key customers
- IQVIA Holdings Inc. - Segment focus
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product and service
- Randox Laboratories Ltd. - Key offerings
- Randox Laboratories Ltd. - Key customers
- Randox Laboratories Ltd. - Segment focus
- RenalSense Ltd. - Overview
- RenalSense Ltd. - Product and service
- RenalSense Ltd. - Key offerings
- RenalSense Ltd. - Key customers
- RenalSense Ltd. - Segment focus
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key offerings
- Siemens AG - Key customers
- Siemens AG - Segment focus
- SphingoTec GmbH - Overview
- SphingoTec GmbH - Product and service
- SphingoTec GmbH - Key offerings
- SphingoTec GmbH - Key customers
- SphingoTec GmbH - Segment focus
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Key customers
- Thermo Fisher Scientific Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global renal biomarkers market: Abbott Laboratories, bioMerieux SA, BioPorto AS, F. Hoffmann-La Roche Ltd., IQVIA Holdings Inc., Randox Laboratories Ltd., RenalSense Ltd., Siemens AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rapid increase in the aging population."
According to the report, one of the major drivers for this market is the rising prevalence of chronic kidney diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- bioMerieux SA
- BioPorto AS
- F. Hoffmann-La Roche Ltd.
- IQVIA Holdings Inc.
- Randox Laboratories Ltd.
- RenalSense Ltd.
- Siemens AG
- SphingoTec GmbH
- Thermo Fisher Scientific Inc.
